Pharma

Your Article Summary

See Latest Articles

DeCODE Receives California Clinical Laboratory License
deCODE genetics, 05/15/09

DeCODE genetics announced that it has received a clinical laboratory license from the State of California. The quality and scale of deCODE's in-house, CLIA-registered genotyping laboratory underpins deCODE's global leadership in the discovery of variations in the sequence of the human genome conferring risk of common diseases. The same staff and facility also process deCODE's DNA-based reference laboratory tests for gauging individual risk of major public health challenges ranging from heart attack to breast cancer, as well as the company's pioneering deCODEme scans, the world's first personal genome analysis and focused disease area scans. With this license, California residents can now benefit from the unrivalled quality of deCODE products for understanding risk and, working with their physicians, empowering the prevention of common diseases.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Recombinant Human Erythropoietin, Epogin Injection Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09

Synthon announces European approvals for Raloxifene
Synthon, 12/08/09

US FDA approves SEROQUEL for the pediatric treatment of schizophrenia and bipolar mania
AstraZeneca, 12/07/09

 See all of Drug/Product Approvals